AstraZeneca has partnered with Hong Kong Science and Technology Parks (HKSTP) to set up an incubation program for biomedical startups. The program is designed to attract and support local and overseas startups working to improve the treatment and diagnosis of cancer.
Read more: https://bit.ly/3rMVgiC